Literature DB >> 29752187

Clinical outcomes after varicose vein procedures in octogenarians within the Vascular Quality Initiative Varicose Vein Registry.

Danielle C Sutzko1, Andrea T Obi2, Andrew S Kimball2, Margaret E Smith2, Thomas W Wakefield2, Nicholas H Osborne2.   

Abstract

BACKGROUND: Whereas chronic venous insufficiency and varicose veins (VVs) are a universally recognized problem, they are frequently underappreciated as major contributors to long-term morbidity in the elderly despite the increasing prevalence with age. Previous studies have demonstrated that chronic venous insufficiency and VV treatments in patients ≥65 years old yield an overall benefit; however, there have been few data as to whether octogenarians are undergoing these procedures and with what success. As such, our objectives were to investigate the procedures selected, to examine clinical outcomes after VV procedures in elderly patients ≥80 years old, and to explore complication rates (both systemic and leg specific) after VV procedures in patients ≥80 years old.
METHODS: We performed a retrospective review using the Vascular Quality Initiative Varicose Vein Registry of all VV procedures performed for ≥C2 disease from January 2015 to February 2017. We divided all procedures into three age groups: patients <65 years, patients ≥65 to 79 years, and patients ≥80 years. Statistical testing included χ2 test for categorical variables and Student t-test for continuous variables. Two comparisons were performed: first, comparing patients <65 years old with patients ≥65 to 79 years old; and second, comparing patients ≥65 to 79 years old with patients ≥80 years old.
RESULTS: There were a total of 12,262 procedures performed, with 8608 procedures in the patients <65 years, 3226 in patients 65 to 79 years, and 428 procedures in patients ≥80 years. A total of 22,050 veins were treated during the 12,262 procedures. Almost half of procedures (46.51%; n = 5703) had only one vein treated during a single procedure. Between age groups, the percentage of one vein treated increased as the patient's age increased, ranging from 45.39% (n = 3875) for patients <65 years to 48.55% (n = 1555) for patients between 65 and 79 years and 64.08% (n = 273) for patients ≥80 years. Patients in the group ≥80 years had an overall lower average body mass index and were more likely to be receiving anticoagulation and to undergo truncal procedures alone compared with the other groups. The group ≥80 years had a significant improvement in both Venous Clinical Severity Score (4.37 ± 4.16; P < .001) and patient-reported outcomes (8.79 ± 7.27; P < .001) from before to after the procedure. Overall complications were low in all age groups. The octogenarians had no higher risk of systemic complications.
CONCLUSIONS: Vascular specialists are performing VV procedures in octogenarians and are more likely to perform truncal only therapy. In addition, octogenarians have statistically significant improvement of Venous Clinical Severity Score and patient-reported outcomes with a low risk of complications despite more advanced venous disease at presentation.
Copyright © 2018 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clinical, Etiology, Anatomy, and Pathophysiology (CEAP); Octogenarian; Patient-reported outcomes (PROs); Varicose veins; Vascular Quality Initiative Varicose Vein Registry (VQI VVR); Venous Clinical Severity Score (VCSS)

Mesh:

Year:  2018        PMID: 29752187      PMCID: PMC6005729          DOI: 10.1016/j.jvsv.2018.02.008

Source DB:  PubMed          Journal:  J Vasc Surg Venous Lymphat Disord


  23 in total

1.  The clinical impact of iliac venous stents in the management of chronic venous insufficiency.

Authors:  Seshadri Raju; Sam Owen; Peter Neglen
Journal:  J Vasc Surg       Date:  2002-01       Impact factor: 4.268

2.  Risk Factors in Patients with Venous Stasis-Related Skin Lesions without Major Abnormalities on Duplex Ultrasonography.

Authors:  Kotaro Suehiro; Noriyasu Morikage; Osamu Yamashita; Takasuke Harada; Makoto Samura; Yuriko Takeuchi; Takahiro Mizoguchi; Kimikazu Hamano
Journal:  Ann Vasc Dis       Date:  2016-08-29

Review 3.  The epidemiology of chronic venous insufficiency and varicose veins.

Authors:  Jennifer L Beebe-Dimmer; John R Pfeifer; Jennifer S Engle; David Schottenfeld
Journal:  Ann Epidemiol       Date:  2005-03       Impact factor: 3.797

4.  Age is not a barrier to good outcomes after varicose vein procedures.

Authors:  Danielle C Sutzko; Elizabeth A Andraska; Andrea T Obi; Mikel Sadek; Lowell S Kabnick; Thomas W Wakefield; Nicholas H Osborne
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2017-09

5.  The impact of surgery for colorectal cancer on quality of life and functional status in the elderly.

Authors:  Tara M Mastracci; Samantha Hendren; Brenda O'Connor; Robin S McLeod
Journal:  Dis Colon Rectum       Date:  2006-12       Impact factor: 4.585

6.  The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum.

Authors:  Peter Gloviczki; Anthony J Comerota; Michael C Dalsing; Bo G Eklof; David L Gillespie; Monika L Gloviczki; Joann M Lohr; Robert B McLafferty; Mark H Meissner; M Hassan Murad; Frank T Padberg; Peter J Pappas; Marc A Passman; Joseph D Raffetto; Michael A Vasquez; Thomas W Wakefield
Journal:  J Vasc Surg       Date:  2011-05       Impact factor: 4.268

7.  Distribution and prevalence of reflux in the superficial and deep venous system in the general population--results from the Bonn Vein Study, Germany.

Authors:  Uldis Maurins; Barbara H Hoffmann; Christian Lösch; Karl-Heinz Jöckel; Eberhard Rabe; Felicitas Pannier
Journal:  J Vasc Surg       Date:  2008-06-30       Impact factor: 4.268

8.  Comparison of surgery and compression with compression alone in chronic venous ulceration (ESCHAR study): randomised controlled trial.

Authors:  Jamie R Barwell; Colin E Davies; Jane Deacon; Kate Harvey; Julia Minor; Antonio Sassano; Maxine Taylor; Jenny Usher; Clare Wakely; Jonathan J Earnshaw; Brian P Heather; David C Mitchell; Mark R Whyman; Keith R Poskitt
Journal:  Lancet       Date:  2004-06-05       Impact factor: 79.321

9.  Age, body mass index and severity of primary chronic venous disease.

Authors:  Dalibor Musil; Marketa Kaletova; Jiri Herman
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2011-12       Impact factor: 1.245

10.  The VVSymQ® instrument: Use of a new patient-reported outcome measure for assessment of varicose vein symptoms.

Authors:  Jean Paty; Diane M Turner-Bowker; Celeste A Elash; David Wright
Journal:  Phlebology       Date:  2015-07-15       Impact factor: 1.740

View more
  4 in total

1.  Effect of concomitant deep venous reflux on truncal endovenous ablation outcomes in the Vascular Quality Initiative.

Authors:  Craig S Brown; Nicholas H Osborne; Gloria Y Kim; Danielle C Sutzko; Thomas W Wakefield; Andrea T Obi; Peter K Henke
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2020-06-24

2.  Outcomes after truncal ablation with or without concomitant phlebectomy for isolated symptomatic varicose veins (C2 disease).

Authors:  Craig S Brown; Andrea T Obi; Jack L Cronenwett; Lowell Kabnick; Thomas W Wakefield; Nicholas H Osborne
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2020-06-02

3.  Comparison of unilateral vs bilateral and staged bilateral vs concurrent bilateral truncal endovenous ablation in the Vascular Quality Initiative.

Authors:  Craig S Brown; Nicholas H Osborne; Gloria Y Kim; Danielle C Sutzko; Thomas W Wakefield; Andrea T Obi; Issam Koleilat
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2020-05-26

4.  Investigation of association between genetic polymorphisms of MMP2, MMP8, MMP9 and TIMP2 and development of varicose veins in the Slovak Population - pilot study.

Authors:  J Mazuchová; E Halašová; J Mazuch; M Šarlinová; V Valentová; M Franeková; Š Zelník; K Krkošková; K Javorka; M Péč; M Grendár
Journal:  Physiol Res       Date:  2020-12-31       Impact factor: 1.881

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.